Screener
UroGen Pharma URGN Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $79.13M-14.8% | $109.97M+5.7% | $110.75M-35.6% | $90.04M-27.9% | $92.9M-57.8% | ||
| $28.84M-55.0% | $30.31M-67.0% | $9.71M-85.0% | $36.99M-70.3% | $64.05M+203% | ||
| $88.76M+352% | $55.41M+182% | $33.08M+62.9% | $19.7M-13.6% | $19.65M+12.8% | ||
| $24.59M+245% | $20.92M+176% | $16.46M+78.4% | $8.34M+9.8% | $7.13M-4.2% | ||
| $235.43M+19.6% | $237.46M+0.1% | $186.02M-32.6% | $168.55M-42.9% | $196.87M-29.4% | ||
| $597K-13.2% | $616K-1.8% | $637K-2.7% | $695K+14.3% | $688K+18.6% | ||
| $252.59M+21.0% | $253.69M+2.5% | $200.46M-29.8% | $185.05M-38.7% | $208.72M-25.9% | ||
| $39.95M+29.0% | $35.35M+16.6% | $27.72M+1.0% | $26.17M+33.0% | $30.96M+30.3% | ||
| $1.41M— | —— | $1.27M— | —— | —— | ||
| $61.92M+30.2% | $50.64M+20.6% | $46.42M+1.0% | $42.24M+28.8% | $47.55M+38.9% | ||
| $188.73M+54.1% | $189.53M+55.2% | $122.21M+0.4% | $122.11M+0.3% | $122.51M+25.2% | ||
| $384.99M+27.4% | $377.94M+28.5% | $305.93M+3.9% | $300.45M+8.7% | $302.09M+20.1% | ||
| $135K+7.1% | $134K+6.3% | $133K+15.7% | $128K+11.3% | $126K+12.5% | ||
| -$997.64M-10.8% | -$983.29M-15.7% | -$959.72M-19.0% | -$933.35M-21.4% | -$900.01M-20.8% | ||
| -$132.4M-41.8% | -$124.25M-167% | -$105.47M-1,098% | -$115.41M-552% | -$93.38M-408% | ||
| $252.59M+21.0% | $253.69M+2.5% | $200.46M-29.8% | $185.05M-38.7% | $208.72M-25.9% |
FAQ
- What are UroGen Pharma's total assets?
- UroGen Pharma (URGN) holds $252.6M in total assets, up 21.0% year over year.
- How much debt does UroGen Pharma have?
- UroGen Pharma carries $197.5M in total debt against -$132.4M of shareholders' equity, a debt-to-equity ratio of 4.81.
- How much cash does UroGen Pharma have?
- UroGen Pharma holds $79.1M in cash and equivalents.
- Can UroGen Pharma cover its short-term obligations?
- Its current ratio is 3.80 — current assets exceed current liabilities.
- Where does UroGen Pharma's balance sheet data come from?
- Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
